Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 45 medicines
AEMPS · 27 medicines
FDA · 23 medicines
AIFA · 14 medicines
HSA · 13 medicines
ALIMS · 11 medicines
SFDA · 11 medicines · Historical list
MS · 9 medicines · Historical list
HALMED · 6 medicines
PHARMAC · 6 medicines
TFDA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
26 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Naproxen | United States | 375MG, 500MG | tablet, delayed release | Marketed | Novitium Pharma |
| Naproxen | United States | 25MG/ML | suspension | Marketed | Novitium Pharma |
| Naproxen | United States | 250MG, 375MG, 500MG | tablet | Marketed | Pharmobedient |
| Naproxen Sodium | United States | 375MG BASE, 500MG BASE, 750MG BASE | tablet, extended release | Marketed | Actavis Labs FL INC |
| Naproxen Sodium | United States | 220MG, 250MG BASE, 500MG BASE | tablet | Marketed | Aurobindo Pharma LTD |
| Naproxen Sodium | United States | 200MG BASE | capsule | Marketed | Puracap Pharm LLC |
| Naproxen and Esomeprazole MagnesiumCombination | United States | 20MG BASE; 375MG, 20MG BASE; 500MG | tablet, delayed release | Marketed | Actavis Labs FL INC |
| Naproxen Sodium and Diphenhydramine HydrochlorideCombination | United States | 25MG; 220MG | tablet | Marketed | P and L |
| Naproxen Sodium and Pseudoephedrine HydrochlorideCombination | United States | 220MG; 120MG | tablet, extended release | Marketed | DR Reddys Labs INC |
| Naprosyn | United States | 25MG/ML | suspension | Marketed | Atnahs Pharma US |
| Sumatriptan and Naproxen SodiumCombination | United States | 500MG; 85MG BASE | tablet | Marketed | Sun Pharm |
| Naprelan | United States | 375MG BASE, 500MG BASE, 750MG BASE | tablet, extended release | Marketed | Twi Pharms |
| Naprosyn | United States | 250MG, 375MG, 500MG | tablet | Marketed | Atnahs Pharma US |
| EC-Naprosyn | United States | 375MG, 500MG | tablet, delayed release | Marketed | Atnahs Pharma US |
| Anaprox DS | United States | 500MG BASE | tablet | Marketed | Atnahs Pharma US |
| Anaprox | United States | 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Atnahs Pharma US |
| Aleve | United States | 220MG | tablet | Marketed | Bayer |
| TreximetCombination | United States | 500MG; 85MG BASE, 60MG; 10MG BASE | tablet | Marketed | Currax |
| Aleve-D Sinus & ColdCombination | United States | 220MG; 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, extended release | Not marketed | Bayer |
| Sumatriptan; Naproxen SodiumCombination | United States | 85MG; 500MG | tablet | Tentative approval | Par Pharm |
| Aleve PMCombination | United States | 25MG; 220MG | tablet | Marketed | Bayer Hlthcare |
| Mucinex 12HR Cold & Fever Multi-SymptomCombination | United States | 30MG; 600MG; 110MG | tablet, extended release | Marketed | RB HLTH |
| VimovoCombination | United States | 20MG BASE; 375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 20MG BASE; 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, delayed release | Not marketed | Horizon |
| Prevacid Naprapac 250 (Copackaged)Combination | United States | 15MG,N/A; 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule, delayed rel pellets, tablet | Not marketed | Takeda Pharms Na |
| Prevacid Naprapac 375 (Copackaged)Combination | United States | 15MG,N/A; 375MG | capsule, delayed rel pellets, tablet | Not marketed | Takeda Pharms Na |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
